Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2007
05/29/2007US7223540 Detecting signals in samples; medical diagnosis
05/29/2007US7223538 Gene expression layouts; immobilization on support; hybrid detector
05/29/2007US7223537 Particle for use in detection of protein binding positions; antitumor agents
05/29/2007US7223535 Using epitopic amino acid sequences to detect/diagnose hepatitis A viral infection; immunoassay
05/29/2007US7223534 Based on pattern of active and deactivated areas of receptive material
05/29/2007US7223533 Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways
05/29/2007US7223532 Blood compatible polymer surfaces
05/29/2007US7223427 Beverage maker interface
05/29/2007US7223410 Inactivated respiratory syncytial viral vaccines
05/29/2007US7223395 Blocking leukocyte emigration and inflammation by interfering with CD99/HEC2
05/29/2007US7223394 Human antibodies that bind human TNFα
05/29/2007US7223393 Monoclonal antibodies for use in the prevention and treatment of cell proliferative and skin disorders; immunotherapy; antitumor agents
05/29/2007US7223368 Diffraction-based diagnostic devices
05/29/2007US7223366 MEMS membrane based sensor
05/29/2007US7223365 Device and method for detecting the coagulation functions of global, especially primary hemostasis
05/29/2007US7223363 Providing a fluidic interface to slides bearing microarrays of biomolecules or other samples immobilized thereon to perform a variety of chemical reactions or processing steps on the slide. An interface device seals against the slide to form a
05/29/2007US7223346 A centrifugal spin-separator with a float in the cavity that has a density between the erythrocytes and plasma and moves through the sedimenting erythrocytes during centrifugation and releases trapped platelets
05/29/2007US7223330 Biosensor, biosensor array and method for detecting macromolecular biopolymers with a biosensor
05/29/2007US7223236 System and method for monitoring user-related data from a person
05/29/2007US7223235 System and method for monitoring blood pressure from a person
05/29/2007US7222519 Soil moisture content measurement system and method
05/29/2007US7222518 Transformer monitoring system
05/29/2007US7222515 Impact test apparatus and impact test method
05/29/2007CA2431674C Device and method for measuring breath alcohol
05/29/2007CA2386642C Electrochemiluminescence helicase assay
05/29/2007CA2352184C Screening test for early detection of colorectal cancer
05/29/2007CA2306885C Apparatus and method for determining a person's sobriety
05/29/2007CA2248189C System for determining analyte concentration
05/29/2007CA2241324C Displacement assay on a porous membrane
05/29/2007CA2202367C Deposit assessment methodology of bacillus thuringiensis delta-endotoxin
05/29/2007CA2170538C Coatable dry reagent composition for blood coagulation assays and method of its use
05/29/2007CA2137863C Ultraviolet light chamber
05/24/2007WO2007059491A2 Novel hydrogels and uses thereof
05/24/2007WO2007059332A2 Platelet aggregation assays
05/24/2007WO2007059313A1 Method to assess breast cancer risk
05/24/2007WO2007059312A2 Methods and compositions comprising non-natural amino acids
05/24/2007WO2007059296A2 Ligands for mineralocorticoid receptor (mr) and methods for screening for or designing mr ligands
05/24/2007WO2007059242A1 Low-density lipoprotein receptor-related protein 2 clears amyloid-beta peptide a cross the blood-brian barrier via apolipoprotein j
05/24/2007WO2007059166A2 Peptide sequence that promotes tumor invasion
05/24/2007WO2007059143A2 Methods of identifying and treating individuals exhibiting mdr-1 overexpression with protein tyrosine kinase inhibitors and combinations thereof
05/24/2007WO2007059094A2 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
05/24/2007WO2007059082A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen
05/24/2007WO2007059065A2 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
05/24/2007WO2007059048A1 Compact foldable meter
05/24/2007WO2007059007A2 Markers of definitive endoderm
05/24/2007WO2007058999A1 Test sensor reagent having cellulose polymers
05/24/2007WO2007058987A1 Methods of identifying compounds that inhibit notch cleavage
05/24/2007WO2007058977A2 Kifs as modifiers of the rho pathway and methods of use
05/24/2007WO2007058965A1 P66-shc as predictive marker in cancer treatment
05/24/2007WO2007058933A2 Melks as modifiers of the rho pathway and methods of use
05/24/2007WO2007058930A1 Human g protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto
05/24/2007WO2007058860A2 Mrhos as modifiers of the rho pathway and methods of use
05/24/2007WO2007058804A1 Dielectrophoretic tweezers apparatus and methods
05/24/2007WO2007058725A2 Engineered antibody fragment that irreversibly binds an antigen
05/24/2007WO2007058654A1 Reduction of non-specific binding in assays
05/24/2007WO2007058588A1 Monoclonal antibodies against apolipoprotein m
05/24/2007WO2007058461A1 Novel quantitative and qualitative analysis apparatus for measuring the body fluid
05/24/2007WO2007058454A1 System for detecting molecular interactions
05/24/2007WO2007058384A1 Method of suppressing replication of hepatitis c virus, inhibitor of replication of the virus and method of screening for the same
05/24/2007WO2007058336A1 SCREENING METHOD AND IDENTIFICATION METHOD FOR SUBSTANCE CAPABLE OF INHIBITING DEGRANULATION REACTION OR PROSTAGLANDIN D2 PRODUCTION IN MAST CELL THROUGH Rec168, AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE COMPRISING THE SUBSTANCE
05/24/2007WO2007058198A1 Apparatus for simply determining fibrous mineral and method for simply determining fibrous mineral
05/24/2007WO2007058129A1 Method of assaying antigen and kit to be used therein
05/24/2007WO2007058021A1 Animal model and method for producing the same
05/24/2007WO2007057989A1 Method of liquid droplet formation and transport, apparatus therefor and particle manipulating apparatus
05/24/2007WO2007057947A1 Filter unit for separating blood and vacuum sampling tube
05/24/2007WO2007057912A2 Nanoparticle vibration and acceleration sensors
05/24/2007WO2007057891A2 Methods and kits for detecting fungal infection
05/24/2007WO2007057746A2 Focused microarray and methods of diagnosing chemotherapeutic drug resistance in a cancer cell
05/24/2007WO2007057744A2 Fluid reservoir
05/24/2007WO2007057704A1 Test device
05/24/2007WO2007057670A1 Nidogen/snep-iike molecule
05/24/2007WO2007057644A2 Method of measuring the affinity of biomolecules
05/24/2007WO2007057548A2 Method for diagnosticating hepatic diseases and for screening molecules for treating said diseases
05/24/2007WO2007057473A1 Method for the detection of decomposition processes
05/24/2007WO2007057468A1 Method and complete system for developing formulations and the in vitro testing thereof with good predictability of the absorption in vivo, high throughput and low requirement of active substance
05/24/2007WO2007057437A1 A method for specific detection of legionella pneumophila
05/24/2007WO2007057428A1 Chromophore containing ligands for characterisation of receptors for binding and activation
05/24/2007WO2007057395A2 Biomarkers for anti-nogo-a antibody treatment in spinal cord injury
05/24/2007WO2007057195A1 Distributed measurement spots and reference spots, especially for chemosensors and biosensors
05/24/2007WO2007057173A2 METHODS AND DEVICES FOR SELECTING COMPOUNDS THAT INTERACT WITH IMPORTIN α 7 AND RELATED USES THEREOF
05/24/2007WO2007057160A2 Apparatus for the measurement of a streaming potential of a liquid containing solid matter
05/24/2007WO2007057062A1 Human bocavirus and methods of diagnosis and treatment
05/24/2007WO2007057057A1 Pvdf membranes
05/24/2007WO2007056885A2 Method for characterising effect yarn
05/24/2007WO2007056884A2 Method for characterising effect yarn
05/24/2007WO2007056883A2 Method for characterising effect yarn
05/24/2007WO2007056870A1 Methods and compositions for pharmacologically controlled targeted immunotherapy
05/24/2007WO2007056861A1 Sirna silencing of influenza virus gene expression
05/24/2007WO2007056858A1 Anti-alpha2 integrin antibodies and their uses
05/24/2007WO2007056825A1 Method and probes for identifying a nucleotide sequence
05/24/2007WO2007056812A1 A molecule and chimeric molecules thereof
05/24/2007WO2007056788A1 Histaminase determination
05/24/2007WO2007044712A3 Portable materials and methods for ultrasensitive detection of pathogens and bioparticles
05/24/2007WO2007039699A3 Proteinaceous substrate for the detection of calpain-3 activity
05/24/2007WO2007038523A3 Method of isolating analytes from a sample
05/24/2007WO2007037133A9 Method for evaluation of compound capable of acting on plk3
05/24/2007WO2007029030A3 Method for identifying modulators of gamma secretase or notch
05/24/2007WO2007028259A3 Antigens for vaccination against and detection of mycoplasma suis
05/24/2007WO2007028163A8 Biocompatible fluorescent imaging agents
05/24/2007WO2007026140A3 Use of a labelled marker for determinating the kidney function